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east Ypt1p-interacting protein (Yip1p) belongs to a
conserved family of transmembrane proteins that in-
teract with Rab GTPases. We encountered Yip1p as
a constituent of ER-derived transport vesicles, leading us
to hypothesize a direct role for this protein in transport
through the early secretory pathway. Using a cell-free assay
that recapitulates protein transport from the ER to the Golgi
complex, we ﬁnd that afﬁnity-puriﬁed antibodies directed
against the hydrophilic amino terminus of Yip1p potently
inhibit transport. Surprisingly, inhibition is speciﬁc to the
COPII-dependent budding stage. In support of this in vitro
Y
 
observation, strains bearing the temperature-sensitive 
 
yip1-4
 
allele accumulate ER membranes at a nonpermissive
temperature, with no apparent accumulation of vesicle
intermediates. Genetic interaction analyses of the 
 
yip1-4
 
mutation corroborate a function in ER budding. Finally,
ordering experiments show that preincubation of ER
membranes with COPII proteins decreases sensitivity to
anti-Yip1p antibodies, indicating an early requirement for
Yip1p in vesicle formation. We propose that Yip1p has a
previously unappreciated role in COPII vesicle biogenesis.
 
Introduction
 
The eukaryotic secretory pathway responsively delivers proteins
and lipids to their correct destinations. Transport though
the secretory pathway is mediated by membrane vesicles
and/or tubules that form from a donor compartment and
fuse selectively with an acceptor. Specific cytosolic coat pro-
tein complexes and conserved membrane fusion factors such
as Rab GTPases and SNARE proteins are known to catalyze
many of these intracellular transport reactions (Mellman and
 
Warren, 2000). Although several of these transport components
are characterized, it is less clear how compartment-specific
factors interface with the conserved machinery and how
budding and fusion stages are coordinated.
Transport between the ER and Golgi complex in the early
secretory pathway also relies on GTPases and SNARE proteins.
More specifically, the Rab GTPase Ypt1p is required for
transport to the Golgi complex in yeast, and is localized pri-
marily to Golgi membranes (Segev et al., 1988). To identify
other cellular factors that bind to Ypt1p, yeast two-hybrid
approaches uncovered a Ypt1p-interacting protein (Yip1p)
that is essential for transport through the early secretory
pathway (Yang et al., 1998). Yip1p is a 27-kD integral mem-
brane protein predicted to span the membrane multiple
times. The amino-terminal hydrophilic domain of Yip1p
faces the cytosol and is sufficient for Ypt1p interaction.
Yip1p also displays direct interactions with several other Rab
GTPases in yeast including Ypt31p and Sec4p. Yip1p binding
to Rabs depends on an intact carboxy-terminal CAAX motif
and prenylation of these GTPases (Yang et al., 1998; Calero
and Collins, 2002). The nucleotide status of the GTPase
seems less critical for these associations.
Yip1p not only associates with Rab GTPases, but forms a
heteromeric complex with a related integral membrane pro-
tein termed Yip1p-interacting factor (Yif1p). Yif1p shares a
common domain topology with Yip1p, binds to Rab GTPases
through a cytoplasmically exposed amino-terminal domain,
and is required for transport through the early secretory
pathway (Matern et al., 2000). Additional reports have
shown that yeast cells contain an extended family of Yip1p
related proteins that appear to form mixed heteromeric com-
plexes with one another. This family displays some func-
tional overlap and may act more broadly in intracellular
transport (Calero and Collins, 2002; Calero et al., 2002).
The subcellular distribution and molecular function of the
Yip family of proteins remains to be determined.
In this report, we investigate the role of Yip1p in protein
transport between the ER and Golgi complex. Using cell-
free assays that recapitulate subreactions in this transport
process, we observed that antibody inhibition of Yip1p
activity and mutations within the amino-terminal cytosolic
domain of Yip1p inhibit COPII-dependent vesicle budding
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from the ER. Moreover, these Yip1p-specific inhibitors do not
directly interfere with the vesicle tethering or fusion stages of
ER-derived vesicles with Golgi membranes. Our in vivo analy-
ses also support a role for Yip1p in budding from the ER.
These results are surprising in light of the fact that Ypt1p does
not appear to be required for COPII-dependent budding.
 
Results
 
Anti-Yip1p antibodies inhibit transport to the Golgi 
complex in vitro
 
Genetic and biochemical experiments have indicated a re-
quirement for Yip1p in transport between the ER and the
Golgi complex. Conditionally lethal 
 
yip1
 
 mutants display
defects in protein secretion, and morphological analyses
demonstrated that cells depleted of Yip1p accumulate mem-
branes of the ER (Yang et al., 1998). Biochemical experi-
ments have shown that Yip1p can physically associate with
Ypt1p (Yang et al., 1998), a small GTPase required for ER/
Golgi transport (Segev et al., 1988). Given these findings,
we sought to define the function of Yip1p more specifically
using a reconstituted cell-free assay that measures protein
transport to the Golgi complex. For this assay, washed
semi-intact cell membranes containing [
 
35
 
S]glycopro-
 
 
 
-fac-
tor (gp
 
 
 
f) in the ER are incubated with purified factors
(COPII, Uso1p, and LMA1) to drive transport of [
 
35
 
S]gp
 
 
 
f
to the Golgi complex (Barlowe, 1997). Upon delivery to the
Golgi complex, gp
 
 
 
f receives outer-chain 
 
 
 
1,6-mannose res-
idues that can be immunoprecipitated with 
 
 
 
1,6-mannose–
specific serum to quantify [
 
35
 
S]gp
 
 
 
f transport (Baker et al.,
1988). To investigate Yip1p function in this assay, we first
prepared affinity-purified antibodies against the hydrophilic
amino terminus of Yip1p (aa residues 1–99). These anti-
Yip1p antibodies were then added to cell-free transport as-
says in an attempt to neutralize Yip1p function. As seen in
Fig. 1 A, reconstituted transport was sensitive to anti-Yip1p
antibodies, whereas preimmune IgGs at comparable concen-
trations did not inhibit transport. The inhibition of anti-
Yip1p antibodies was alleviated if purified MBP-Yip1p was
included in the reaction. This observation indicates MBP-
Yip1p can compete with endogenous Yip1p for antibody
binding, and demonstrates that the antibodies act in a spe-
cific manner.
Subreactions in cell-free transport can be monitored by
following the sedimentation properties of membranes con-
taining [
 
35
 
S]gp
 
 
 
f (Barlowe, 1997). Incubation of washed
semi-intact cell membranes with purified COPII proteins
catalyzes the formation of diffusible vesicles that can be sepa-
rated from larger membranes by centrifugation. When puri-
fied Uso1p is included in this reaction, a significant fraction
of the diffusible vesicles pellet with heavier membranes, pro-
viding a measurement of vesicle tethering. We found that
the inhibitory anti-Yip1p antibodies did not affect vesicle
 
Figure 1.
 
Anti-Yip1p antibodies inhibit in vitro transport between 
the ER and the Golgi complex at the budding stage.
 
 (A) Washed 
wild-type (FY834) semi-intact cells containing [
 
35
 
S]gp
 
 
 
f were 
incubated with Recon proteins (COPII, Uso1p, and LMA1) and an 
ATP regeneration system. After 75 min at 23
 
 
 
C, the amount of 
Golgi-modified [
 
35
 
S]gp
 
 
 
f was measured to determine transport 
efficiency. Where indicated, anti-Yip1p antibodies (40 
 
 
 
g/ml), 
preimmune IgGs (40 
 
 
 
g/ml), or MBP-Yip1p (144 
 
 
 
g/ml) were added 
to reactions. (B) Semi-intact cells prepared as in A were incubated 
with COPII or COPII plus Uso1p to measure budding and tethering 
in the presence or absence of anti-Yip1p antibodies (20 
 
 
 
g/ml). 
After 30 min at 23
 
 
 
C, freely diffusible vesicles containing [
 
35
 
S]gp
 
 
 
f 
were separated from semi-intact cell membranes by centrifugation 
at 18,000 
 
g
 
 and [
 
35
 
S]gp
 
 
 
f quantified by Con A precipitation. (C) Vesicle 
budding as in B with increasing amounts of anti-Yip1p antibodies 
(20–80 
 
 
 
g/ml). No addition (NA) shows level of budding minus 
COPII. (D) Vesicle budding as in B, except cytosol was used to drive 
reactions. Where indicated, anti-Yip1p antibodies (40 
 
 
 
g/ml) and 
MBP-Yip1p (144 
 
 
 
g/ml) were added.T
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tethering to the Golgi complex, but instead inhibited the
budding of COPII vesicles (Fig. 1 B). Titrating the inhibi-
tory effect of anti-Yip1p antibodies on budding showed that
increasing amounts of antibodies inhibited COPII-depen-
dent vesicle budding in a dose-dependent manner (Fig. 1
C). We also examined the influence of anti-Yip1p antibodies
on vesicle budding when reactions were supplied with a
crude cytosolic fraction. As shown in Fig. 1 D, budding re-
mained sensitive to the anti-Yip1p antibodies under this
condition. This observation indicates that other factors
present in a cytosolic extract cannot circumvent the inhibi-
tory effect of the anti-Yip1p antibodies on vesicle budding.
The inhibition of budding by anti-Yip1p antibodies was
surprising, as there is no apparent requirement for Ypt1p in
the COPII-dependent vesicle-budding assay (Cao et al.,
1998). Therefore, we considered the possibility that these
anti-Yip1p antibodies interfered with budding in a non-
specific manner, perhaps by coating ER membranes and
preventing COPII association. Alternatively, the antibodies
could cross-link vesicles to ER membranes or to one another,
producing an aggregate that would pellet under the condi-
tions of our budding assay. These effects would then mask
any later stage requirements for Yip1p in vesicle tethering or
fusion. To address these possibilities, we performed an addi-
tional series of experiments. First, it should be noted that
antibodies against other abundant vesicle proteins such as
Sec22p, Sed5p, and Erv29p do not block budding nonspecif-
ically (Cao et al., 1998; Belden and Barlowe, 2001b; Liu and
Barlowe, 2002). Second, we prepared Fab fragments from
the affinity-purified anti-Yip1p antibodies and observed spe-
cific inhibition of the vesicle-budding stage of cell-free trans-
port (unpublished data). Finally, we generated COPII vesi-
cles containing [
 
35
 
S]gp
 
 
 
f for use in second-stage transport
reactions to determine if anti-Yip1p antibodies influenced
any of the post-budding assays. As seen in Fig. 2 A, addition
of Uso1p to reactions containing isolated vesicles and wild-
type acceptor membranes produced an 
 
 
 
3.7-fold reduction
in diffusible vesicles, indicating efficient tethering of vesicles
to Golgi membranes (Fig. 2 A, compare column 1 with col-
umn 2). Vesicle tethering was unaffected by the addition of
anti-Yip1p antibodies in amounts that effectively block vesi-
cle budding. In columns 4 and 5 of Fig. 2 A, vesicles and ac-
ceptor membranes or vesicles alone were combined with
anti-Yip1p antibodies in the absence of Uso1p. No reduction
in diffusible vesicles was observed for either condition, indi-
cating that an antibody cross-linking event was not responsi-
ble for the observed decrease in vesicle budding.
We also examined the ability of the anti-Yip1p antibodies
to inhibit vesicle fusion in a two-stage reaction. Vesicles con-
taining [
 
35
 
S]gp
 
 
 
f were added to wild-type acceptor mem-
branes with Uso1p and the fusion factor LMA1, in the pres-
ence or absence anti-Yip1p antibodies. As shown in Fig. 2 B,
the addition of Uso1p and LMA1 to the reaction stimulated
fusion 
 
 
 
3.8-fold (Fig. 2 B, compare column 1 with column
2). The addition of anti-Yip1p antibodies to this reaction
did not inhibit fusion (Fig. 2 B, column 3). In contrast, af-
finity-purified antibodies against the SNARE protein Sec22p
effectively block vesicle fusion under these conditions as pre-
viously reported (Liu and Barlowe, 2002). Together, the re-
sults in Fig. 1 and Fig. 2 indicate that Yip1p is required for
in vitro transport of [
 
35
 
S]gp
 
 
 
f to the Golgi complex. These
data show that the anti-Yip1p antibodies potently and spe-
cifically inhibit the budding of COPII vesicles, suggesting a
role for Yip1p in vesicle biogenesis.
 
Anti-Yip1p antibodies block the COPII-dependent 
budding of vesicle proteins
 
Next, we examined whether the inhibition of vesicle bud-
ding by the anti-Yip1p antibodies was restricted to [
 
35
 
S]gp
 
 
 
f
monitored in the budding assay, or reflected a more com-
plete block of vesicle biogenesis from ER membranes. Previ-
ous reports have shown that ER/Golgi SNARE proteins are
efficiently packaged into COPII vesicles (Barlowe et al.,
1994; Rexach et al., 1994). In addition, a group of con-
served transmembrane proteins, termed ER vesicle (Erv)
proteins, are efficiently incorporated into COPII vesicles
(Rexach et al., 1994; Otte et al., 2001). We investigated
Figure 2. Anti-Yip1p antibodies do not inhibit vesicle tethering or 
vesicle fusion in a two-stage reaction. (A) COPII vesicles containing 
[
35S]gp f were synthesized from wild-type (FY834) membranes and 
mixed with wild-type semi-intact cell acceptor membranes. Reactions 
were incubated with Uso1p in the presence or absence of anti-Yip1p 
antibodies (120  g/ml) where indicated. Freely diffusible vesicles 
containing [
35S]gp f were quantified by Con A precipitation. (B) COPII 
vesicles prepared as in A were mixed with wild-type semi-intact cell 
acceptor membranes. Reactions contained Uso1p and LMA1 in the 
presence or absence of anti-Yip1p antibodies (120  g/ml) or anti-
Sec22p antibodies (60  g/ml) where indicated. After 75 min at 
23 C, the amount of Golgi-modified [
35S]gp f was measured to 
determine fusion efficiency.T
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whether anti-Yip1p antibodies affected the incorporation of
these proteins into COPII vesicles. Washed semi-intact cells
were incubated with COPII proteins and an energy regener-
ation system in the presence or absence of anti-Yip1p anti-
bodies. The vesicles synthesized in each condition were then
isolated and analyzed by immunoblotting. As seen in Fig. 3,
COPII proteins catalyzed the efficient and specific incorpo-
ration of certain proteins into vesicles. The SNARE protein
Sec22p, as well as Erv25p, Erv41p, Yif1p, and Yip1p, were
efficiently packaged under these conditions (Fig. 3, lane 2).
The ER resident proteins Sec12p and Sec61p were not effi-
ciently packaged into COPII vesicles, demonstrating selective
sorting in this budding assay. The presence of anti-Yip1p
antibodies in the reaction effectively inhibited budding of
all vesicle proteins examined, whereas preimmune IgGs at a
comparable concentration had no effect (Fig. 3, lane 3 and
lane 4). These results demonstrate the inhibition of vesicle
budding by the anti-Yip1p antibodies occurs in a general
manner, and is not restricted to [
 
35
 
S]gp
 
 
 
f.
 
Mutant y
 
ip1-4
 
 strains accumulate ER membranes 
in vivo
 
We sought additional approaches to study the role of Yip1p
in transport between the ER and Golgi complex. The ther-
mosensitive 
 
yip1-4
 
 allele, which contains a single point mu-
tation (E70K) in the cytoplasmic domain of Yip1p, blocks
secretion and growth when shifted to a restrictive tempera-
ture (Calero et al., 2003). To characterize the morphology of
transport intermediates that may accumulate in 
 
yip1-4
 
strains, thin-section EM was used under conditions that
Figure 3. Anti-Yip1p antibodies block COPII-dependent budding 
of vesicle proteins. COPII-budding reactions were performed from 
wild-type semi-intact cells (FY834) in the presence or absence of 
anti-Yip1p antibodies (40  g/ml) or preimmune IgGs (40  g/ml) as 
indicated. One tenth of a total reaction (T), or budding reactions 
without COPII proteins (lane 1), with COPII proteins (lane 2), with 
COPII plus anti-Yip1p antibodies (lane 3), and with COPII plus pre-
immune antibodies (lane 4) were separated on a 12.5% polyacrylamide 
gel. ER resident proteins (Sec61p and Sec12p) and vesicle proteins 
(Sec22p, Erv25p, Erv41p, Yif1p, and Yip1p) were detected using 
immunoblot. Asterisks indicate antibody heavy chain cross-reactivity 
with secondary antibodies.
Figure 4. Themosensitive yip1-4 mutants display 
morphological phenotypes characteristic of an 
early block in the secretory pathway. Wild-type 
and mutant cells were shifted to 37 C for 40 min 
and then fixed and prepared for EM as described 
under the Materials and methods section. Repre-
sentative thin sections are shown for each condition. 
The white arrows in the sec18-1 panel point to 
transport vesicles that have accumulated in this 
strain. Note that the accumulation of vesicles was 
absent in the yip1-4 and yip1-4 sec18-1 strains. 
Bars, 1  m.T
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highlight membrane and vesicle structures (Kaiser and
Schekman, 1990). Upon shift to 37
 
 
 
C for 40 min, 
 
yip1-4
 
strains show a massive proliferation of ER membranes (Fig.
4), which is commonly observed in the secretory mutants
that block vesicle production from the ER (Novick et al.,
1980). This type of ER accumulation was also reminiscent
of the karmellae-like ER exaggerations formed by overex-
pression of 
 
HMG1
 
 in that the accumulating ER membrane
frequently formed multi-layered aggregates that were asym-
metrically localized in the cell (Wright et al., 1988). How-
ever, unlike the 
 
HMG1
 
 overexpression strains, the ER in
 
yip1-4
 
 strains did not accumulate around the nucleus in an
ordered array, but appeared to extend into the cytoplasm,
sometimes lacking any obvious nuclear association, and was
often positioned underneath the plasma membrane. A very
similar terminal phenotype has been reported under condi-
tions of Yip1p depletion after placing 
 
YIP1
 
 expression under
 
GAL10
 
 control (Yang et al., 1998).
Small 50–60-nm vesicles did not accumulate in the 
 
yip1-4
 
strain, but were clearly observed in a 
 
sec18
 
 mutant (Fig. 4).
The 
 
sec18-1
 
 mutation produces a strong vesicle accumula-
tion phenotype because the corresponding Sec18p protein is
required for vesicle fusion (Wilson et al., 1989; Kaiser and
Schekman, 1990). When the 
 
yip1-4
 
 and 
 
sec18-1
 
 alleles were
combined in a single strain, we observed an ER accumula-
tion phenotype without an accumulation of transport vesi-
cles. This epistatic relationship between 
 
yip1-4
 
 and 
 
sec18-1
 
indicates 
 
yip1-4
 
 inhibits vesicle formation from the ER, and
therefore prevents the accumulation of vesicles that are char-
acteristic of fusion mutants. A similar reversal of the 
 
sec18-1
 
vesicle accumulation phenotype has been reported when 
 
sec
 
mutants that specifically block COPII budding were com-
bined with 
 
sec18-1
 
 (Kaiser and Schekman, 1990). Thus, our
morphological experiments place 
 
YIP1
 
 function in the vesi-
cle-budding stage of transport between the ER and Golgi
compartments and before the action of Sec18p.
We also examined the distribution of an ER-localized pro-
tein in 
 
yip1-4
 
 cells by fluorescence microscopy of GFP-
KDEL. When 
 
yip1-4
 
 mutants were shifted to a restrictive
temperature for 60 min, striking elaborations of the ER were
apparent (Fig. 5 A) while nuclear structures remained intact.
Very similar elaborations of the ER were observed when
GFP-KDEL was expressed in a 
 
sec12
 
 strain under restrictive
conditions (unpublished data). These observations are in ac-
cord with the images obtained by EM showing accumula-
tion of ER membranes in 
 
yip1-4
 
 mutants.
 
Redistribution of Golgi-localized proteins 
to the ER in 
 
yip1-4
 
 strains
 
Proteins that localize to early Golgi compartments continu-
ally cycle through the ER at varying rates. If export from the
ER is blocked, cycling proteins accumulate in the ER
(Schroder et al., 1995; Ward et al., 2001). For example,
Emp47p and Sed5p display Golgi localization patterns in
wild-type cells; however, in a 
 
sec12
 
 strain shifted to the re-
strictive temperature, these proteins redistribute to the ER
(Schroder et al., 1995; Wooding and Pelham, 1998). We
used this approach to determine the influence of the 
 
yip1-4
 
mutation on the localization of Golgi-localized proteins. If
 
YIP1
 
 is required for budding from the ER, we hypothesized
that early Golgi proteins would become ER-localized in the
absence of 
 
YIP1
 
 function.
In this set of experiments, GFP-tagged versions of Sed5p,
Gos1p, and Sft2p were expressed in the 
 
yip1-4 mutant and
monitored by fluorescence at permissive and restrictive temper-
atures (Fig. 5 B). GFP-Sed5p displayed a typical punctate pat-
Figure 5. Distribution of GFP-tagged proteins in wild-type and 
yip1-4 strains. (A) Fluorescence images of GFP-KDEL showing the 
outline of ER membranes in wild-type (RCY1768) and yip1-4 
(RCY1764) strains after 60 min at 37 C. Hoechst stain for DNA 
indicates nuclei remain intact in yip1-4 cells after a 60-min shift to 
the restrictive temperature. (B) GFP-tagged versions of Sed5p, Gos1p, 
and Sft2p were expressed in the yip1-4 strain and monitored by 
fluorescence microscopy at 25 C or after shift to 37 C for 30 min. 
Note the partial localization to perinuclear structures for GFP-Sed5p 
and GFP-Gos1p upon shift to the restrictive temperature. (C) GFP-
Gos1p shifts to a perinuclear distribution when ER export is blocked 
in a sec12-4 strain, whereas GFP-Sft2p remains in a punctate pattern 
as in the yip1-4 strain.T
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tern at a permissive temperature, but upon temperature shift, a
distinct perinuclear localization emerged. Some GFP-Sed5p ap-
peared to remain in spots and may represent Sed5p that func-
tions in later Golgi compartments (Pelham, 2001). GFP-Gos1p
also redistributed to the ER when ER export was blocked, con-
sistent with its proposed role in transport through early Golgi
compartments (McNew et al., 1998; Tsui et al., 2001). In con-
trast, GFP-Sft2p remained in a punctate pattern after tempera-
ture shift as expected for a protein that functions in later Golgi
compartments (Wooding and Pelham, 1998). A very similar ef-
fect on the distribution of GFP-Gos1p and GFP-Sft2p was ob-
served in sec12 strains (Fig. 5 C). These results provide further
support for a Yip1p requirement in export from the ER.
Yip1p cycles between the ER and Golgi compartments
Although Yip1p was detected in ER-derived vesicles, previ-
ous reports indicated that the protein was largely Golgi lo-
calized (Yang et al., 1998). We generated a GFP-Yip1p fu-
sion protein under its native promoter to monitor the
location of Yip1p in live cells. Strains expressing this GFP-
Yip1p fusion as the sole source of Yip1p activity displayed
growth rates that were comparable to wild-type strains (Fig.
6 A). Fluorescence imaging of GFP-Yip1p cells at various
cell cycle stages (Fig. 6 B) revealed both a punctate pattern
typical of Golgi-localized proteins and ring-like perinuclear
structures indicative of ER localization. We also examined
the fate of GFP-Yip1p in a sec12 mutant shifted to 37 C
(Fig. 6 C). If GFP-Yip1p traffics through the ER, we would
expect it to accumulate in the ER when exit from this com-
partment is blocked. Indeed, GFP-Yip1p redistributed to
ER structures under this condition. Finally, we compared
the distribution of endogenous Yip1p under wild-type con-
ditions or under a sec12 block using subcellular fractionation
schemes. Larger ER membranes pellet at a lower g-force
( 13,000 g) than Golgi membranes (100,000 g) when cell
lysates are prepared under specified conditions (Wooding
and Pelham, 1998). As seen in Fig. 6 D, Yip1p was found in
both ER and Golgi fractions in wild-type strains, but shifts
to the ER fraction under a sec12 block. Together with our
budding experiments showing Yip1p is efficiently packaged
into ER-derived vesicles, these results indicate Yip1p cycles
between the ER and Golgi compartments and is dynami-
cally localized to the early secretory pathway.
Mutant yip1-4 cells display a defect in COPII vesicle 
budding in vitro
Our in vivo analyses of yip1-4 mutants indicated a block in
budding from the ER. Next, we examined the yip1-4 strain
in cell-free transport assays to further characterize transport
defects. As shown in Fig. 7 A, yip1-4 cells exhibited a signifi-
cant defect in transport of [
35S]gp f to the Golgi complex in
comparison to an isogenic wild-type strain at 23 C. Specifi-
cally, the yip1-4 membranes displayed a 41% reduction in
[
35S]gp f transport compared with wild-type. A similar re-
sult was obtained when these strains were compared at 29 C,
thus, we could not replicate thermosensitivity of the yip1-4
allele in vitro (unpublished data). However, we examined the
ability of the yip1-4 strain to bud and tether COPII vesicles
to identify the stage at which transport was compromised
(Fig. 7 B). We observed that upon the addition of COPII
proteins, the wild-type membranes budded vesicles at an effi-
ciency of  33%, whereas the yip1-4 membranes budded ves-
icles at an efficiency of only  9%. Importantly, transloca-
tion of [
35S]gp f into the yip1-4 membranes was near the
wild-type level, indicating that the ER membranes were not
generally compromised. When the tethering factor Uso1p
was included in these reactions, we found that wild-type
membranes tethered  45% of the diffusible vesicles and
Figure 6. Yip1p cycles between the ER and Golgi compartments. 
(A) GFP fused to the amino terminus of Yip1p (GFP-Yip1p) comple-
ments a yip1  strain. (B) Cells expressing GFP-Yip1p were analyzed 
by fluorescence imaging. A punctate fluorescence pattern typical of 
Golgi-localized proteins in addition to ring-like perinuclear structures 
of the ER were observed. (C) GFP-Yip1p redistributes to perinuclear 
structures when transport from the ER is blocked in a sec12 strain 
shifted to 37 C for 30 min (D) ER and Golgi membrane fractions 
from WT and sec12-4. Cells were shifted to 37 C for 45 min before 
lysis and collection of membrane fractions. The contents of ER (P13) 
and Golgi (P100) fractions were monitored by immunoblot. Sec61p 
serves as an ER marker, whereas Och1p is a Golgi-localized protein.T
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yip1-4 membranes tethered  47% of the diffusible vesicles.
These results indicate that the yip1-4 membranes can effec-
tively tether COPII vesicles to the Golgi, but are defective in
their ability to bud COPII vesicles from ER membranes.
Given that the yip1-4 strain exhibited a budding defect
even at the permissive temperature of 23 C, we were con-
cerned that this defect could be an indirect consequence of
this point mutation on both ER and Golgi membranes. To
further monitor the integrity of Golgi membranes, we also
determined the acceptor activity of yip1-4 membranes
when supplied with wild-type vesicles. Vesicles containing
[
35S]gp f were generated from wild-type microsomes and pu-
rified on density gradients (Barlowe, 1997). The vesicles were
then added to wild-type or yip1-4 acceptor membranes in the
presence or absence of purified fusion factors. As shown in
Fig. 7 C, the combination of wild-type vesicles, wild-type ac-
ceptor membranes, and fusion factors produced a fusion effi-
ciency of  15% (column 2). As shown in column 4, the
combination of wild-type vesicles, yip1-4 acceptor mem-
branes, and fusion factors produced a comparable amount of
fusion ( 10%), indicating that the mutant cells retained
functional acceptor activity. These results suggest the Golgi
complex in the yip1-4 strain is functionally competent for
tethering and fusion in vitro. Based on these findings, we
conclude that the transport defect in the yip1-4 strain is most
specific to the budding stage, and that the membranes of the
early secretory pathway are not generally compromised.
The yip1-4 cells were also examined for their ability to
package proteins other than [
35S]gp f into COPII vesicles.
COPII vesicles were generated from equivalent amounts of
wild-type or yip1-4 semi-intact cells and analyzed by immu-
noblot. As shown in Fig. 8, wild-type membranes efficiently
packaged Sec22p, Erv25p, Erv46p, Yif1p, and Yip1p into
vesicles in a COPII-dependent fashion. In contrast, yip1-4
membranes packaged these vesicle proteins at significantly
lower efficiencies upon reconstitution of COPII budding.
This result mirrors the decrease observed in packaging of
[
35S]gp f, indicating an overall defect in COPII vesicle bio-
genesis. In summary, the in vitro budding defects caused by
the yip1-4 mutation are in accord with the phenotypes ob-
served by microscopic inspection of the yip1-4 strain and
with our observation that anti-Yip1p antibodies block the
production of COPII vesicles in vitro.
Genetic interaction analysis of yip1-4
The growth phenotype of strains that combine two distinct
mutations can indicate a functional connection between two
Figure 7. yip1-4 membranes display a defect in COPII vesicle 
budding in vitro. (A) Washed semi-intact cells containing [
35S]gp f 
were prepared from wild-type (RCY1768) and yip1-4 (RCY1764) 
strains. Semi-intact cells were incubated with COPII proteins, 
Uso1p, LMA1, and an ATP regeneration system. After 75 min at 
23 C, the amount of Golgi-modified [
35S]gp f was measured to 
determine transport efficiency. (B) Semi-intact cells from wild-type 
and mutant strains were prepared as in A and incubated with COPII 
or COPII plus Uso1p to measure vesicle budding and tethering. 
(C) COPII vesicles containing [
35S]gp f were synthesized from wild-
type microsomes and purified on density gradients. Purified vesicles 
were mixed with wild-type or yip1-4 semi-intact cell acceptor 
membranes in second-stage assays in the presence or absence of 
Uso1p and LMA1. After 75 min at 23 C, the amount of Golgi-modified 
[
35S]gp f was measured to determine transport efficiency.
Figure 8. COPII-dependent budding of vesicle proteins is reduced 
in the yip1-4 strain. COPII-budding reactions in wild-type (RCY1768) 
or yip1-4 (RCY1764) semi-intact cells. One tenth of a total reaction 
(T), budded vesicles isolated after incubation with COPII proteins 
( ), or a mock reaction without COPII proteins ( ) were separated 
on a 12.5% polyacrylamide gel. Sec61p (ER resident protein) and 
Sec22p, Erv25p, Erv46p, Yif1p, and Yip1p (vesicle proteins) were 
detected by immunoblot.T
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genes. To test if the yip1-4 allele influences the growth proper-
ties of other ER/Golgi transport mutants, specific mutants
were combined with yip1-4. The double mutants were con-
structed in haploid strains in which viability was ensured by
expression of YIP1 from an extrachromosomal URA3-linked
plasmid. In these strains, loss of the YIP1-URA3 plasmid can be
scored by growth on media containing 5-fluorouracil (5-FOA)
and demonstrates viability of the double mutant. As examples
of this approach, no growth of the yip1-4 sec12-4 strain was
observed on 5-FOA plates, whereas viable yip1-4 sec17ts colo-
nies were observed (Fig. 9). This result indicates that yip1-4
displays a synthetic lethal relationship with the budding mu-
tant sec12-4. Several other trafficking mutants that act in spe-
cific stages of transport between the ER and Golgi complex
have been characterized. We constructed pair-wise combina-
tions of these mutants with yip1-4 and tested for growth on
5-FOA media (Table I). Interestingly, we observed synthetic
lethal relationships between yip1-4 and mutants involved in
COPII budding from the ER, including sec12-4, sec13-1, and
sec23-1. The only other lethal combinations observed were
with the sec21-1 and uso1-1 mutations, which act in COPI-
and COPII-dependent transport pathways, respectively (Hoso-
buchi et al., 1992; Cao et al., 1998). A variety of other ER/
Golgi mutants did not display synthetic lethality when com-
bined with yip1-4, indicating specificity in the interactions de-
tected. These genetic tests provide further evidence for Yip1p
function in vesicle budding from the ER and are consistent
with our biochemical and morphological experiments.
Preincubation of membranes with COPII results in a 
decrease in sensitivity to anti-Yip1p antibodies
Our experiments establish a role for Yip1p in vesicle bud-
ding from the ER. To further refine the stage at which
Yip1p functions during the process of COPII vesicle biogen-
esis, we attempted to order the temporal requirements for
the COPII proteins and Yip1p activity. Wild-type ER mem-
branes containing [
35S]gp f were preincubated with either
COPII or anti-Yip1p antibodies for 5 min at 15 C. In a sec-
ond incubation, factors were then added to each condition,
and the reaction proceeded for an additional 25 min before
vesicle budding was quantified. As shown in Fig. 10 A, pre-
incubation of membranes with COPII proteins followed by
buffer produced a vesicle budding efficiency of  23%. Si-
multaneous addition of COPII proteins and anti-Yip1p an-
tibodies reduced the budding efficiency to  5%. Similarly,
preincubation of membranes with anti-Yip1p antibodies for
5 min followed by the addition of COPII proteins inhibited
vesicle budding. Notably, preincubation of membranes with
COPII followed by the addition of anti-Yip1p antibodies
produced a budding efficiency of  22%, very similar to the
control COPII reaction. One explanation for this result may
be that a majority of vesicle budding occurred during the
5-min COPII preincubation. In this way, second-stage addi-
tion of the anti-Yip1p antibodies would have little or no ef-
fect. To address this issue, we measured COPII budding af-
ter a 5-min incubation at 15 C and found that the level of
budding only reached  8% during the COPII preincuba-
tion stage (Fig. 10 A). It should also be noted that preincu-
bation of membranes with COPII proteins on ice did not
produce resistance to anti-Yip1p antibodies. Therefore, we
conclude that membranes preincubated with COPII pro-
teins at elevated temperatures become insensitive to anti-
Yip1p antibodies. These observations suggest that Yip1p is
required early in the budding reaction.
Next, we investigated the possibility that an individual
COPII component was responsible for producing the de-
crease in sensitivity to anti-Yip1p antibodies during the pre-
incubation step. Given the role of Sar1p in initiating coat as-
sembly, we tested Sar1p as a candidate for this activity.
Wild-type ER membranes containing [
35S]gp f were prein-
cubated with Sar1p or anti-Yip1p antibodies for 5 min at
15 C. In a second incubation, factors were added to each
condition, and then budding reactions continued for 25
Figure 9. Genetic interaction analysis of yip1-4. Strains carrying 
a thermosensitive mutation in genes involved in ER/Golgi transport 
were combined with a yip1  allele together with a wild-type YIP1 
on a URA3 plasmid. Strains also contained vector only, wild-type 
YIP1 LEU2 vector, or a yip1-4 LEU vector. All transformants were 
assessed by plasmid shuffling on 5-fluorouracil at 25 C. Plates con-
taining yip1-4 sec17ts double mutants are shown as an example 
where no genetic interaction was observed. In contrast, yip1-4 
sec12-4 double mutants are shown as an example of complete 
lethality between two mutants. A summary of genetic interaction 
results is shown in Table I.
Table I. Summary of genetic interactions
Allele Viability at 25 C in combination 
with yip1-4
sec12-4  
sec13-1  
sec23-1  
ypt1-3  / 
sec16-2  
ret1-1  
sec20-1  
sec21-1  
sec17ts  
sec18-1  
sec22ts  
bos1-1  
sed5ts  
bet3-1  
uso1-1  
sec34-2  
sec35-1  
bet1-1  T
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min. As shown in Fig. 10 B, preincubation of membranes
with Sar1p alone followed by addition of buffer produced a
budding efficiency of  14%. Preincubation of membranes
with Sar1p followed by the secondary addition of Sec23/24p
and Sec13/31p stimulated budding to an efficiency of
 28%. In contrast, preincubation of membranes with
Sar1p and anti-Yip1p antibodies followed by secondary ad-
dition of Sec23/24p and Sec13/31p produced a budding ef-
ficiency of  8%. Interestingly, preincubation of membranes
with Sar1p followed by addition of Sec23/24p, Sec13/31p,
and anti-Yip1p antibodies yielded a budding efficiency of
 17%, which is intermediate when compared with the sec-
ondary addition of Sec23/24p and Sec13/31p alone. We
also measured the amount of budding during the 5-min
Sar1p preincubation stage and observed an  5% budding
efficiency. Therefore, the amount of vesicle budding that oc-
curred during the Sar1p preincubation step cannot account
for the fraction of vesicle budding that becomes insensitive
to anti-Yip1p antibodies during the second stage. These re-
sults indicate that preincubation of membranes with Sar1p
alone decreases sensitivity to anti-Yip1p antibodies; how-
ever, preincubation with all of the COPII components pro-
vides greater resistance.
Discussion
The Yip1 family of proteins is widespread in nature and has
been implicated in Rab/Ypt function (Yang et al., 1998;
Matern et al., 2000; Calero and Collins, 2002; Calero et al.,
2002). Although these reports indicate that Yip1p and Yif1p
are essential for transport through the early secretory path-
way, their mechanisms of action remain to be elucidated.
We had encountered the Yip1p and Yif1p proteins as con-
stituents of ER-derived transport vesicles in experiments to
identify proteins involved in ER/Golgi transport (Otte et al.,
2001). Given that these proteins appear to cycle between the
ER and Golgi compartments as well as interact with Ypt1p,
we hypothesized that Yip1p would participate in a vesicle
tethering and/or membrane fusion stage. Surprisingly, our
experiments indicate that Yip1p function is required for
biogenesis of COPII-derived vesicles. Antibodies directed
against the amino-terminal cytosolic domain of Yip1p po-
tently inhibited budding of COPII vesicles in assays that fol-
lowed packaging of the soluble secretory cargo gp f and
other integral membrane vesicle proteins. Vesicle tethering
and fusion were not significantly affected by the presence of
anti-Yip1p antibodies.
Genetic analyses provided an independent line of evidence
for Yip1p function in vesicle budding. The thermosensitive
yip1-4 allele caused an accumulation of ER membranes with
no apparent accumulation of 50–60-nm transport vesicle in-
termediates. When the yip1-4 mutation was combined with
the vesicle accumulating sec18-1 mutation, the double mu-
tant accumulated ER structures when shifted to restrictive
temperatures. This result demonstrates a requirement for
YIP1 in the production of vesicles that accumulate in sec18-1
cells. Furthermore, pair-wise combinations of yip1-4 with
other ER/Golgi transport mutants revealed specific inter-
actions with genes (SEC12, SEC13, and SEC23) involved
in formation of COPII vesicles. Mutations that influ-
ence COPI vesicle biogenesis (SEC21) and Golgi tethering
(USO1) also displayed synthetic lethal relationships with
yip1-4, revealing potential roles for Yip1p in Golgi structure
or function. Finally, in vitro analysis of the yip1-4 allele re-
vealed a significant defect in COPII-dependent vesicle bud-
ding, a result that is in good accord with the antibody inhi-
bition analysis. Based on these observations, we propose that
Yip1p acts in vesicle biogenesis and may be required for the
assembly of coat structures, or possibly in the scission of
coated vesicles from the ER.
Our findings are unexpected, given that much of the cur-
rent data regarding Yip1p suggest a role for this protein in
regulating aspects of Rab GTPase function. Indeed, Yip1p
was originally identified as a Ypt1p- and Ypt31p-binding
protein using yeast two-hybrid screens (Yang et al., 1998).
Subsequent reports identified Yif1p as a Yip1p-binding part-
ner, and it has been proposed that a Golgi-localized Yif1p–
Yip1p complex acts to bind Ypt1p and Ypt31p to facilitate
vesicle docking and fusion (Matern et al., 2000). More re-
cent data demonstrate the presence of an extended family of
Figure 10. Preincubation of donor membranes with COPII 
produces a decrease in sensitivity to anti-Yip1p antibodies. 
(A) Washed semi-intact cells containing [
35S]gp f were prepared 
from a wild-type strain (FY834) and treated with either COPII or 
anti-Yip1p antibodies (40  g/ml) for 5 min at 15 C. Secondary 
factors were then added as indicated, and the reactions proceeded 
for an additional 25 min. Freely diffusible vesicles containing 
[
35S]gp f were then separated from semi-intact cell membranes by 
centrifugation and quantified by Con A precipitation. (B) Semi-intact 
cells prepared as in A were treated with Sar1p or anti-Yip1p anti-
bodies alone (40  g/ml) for 5 min at 15 C. Secondary factors were 
then added and diffusible vesicles were quantified as in A.T
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Yip1-related proteins that form mixed heteromeric com-
plexes with one another (Calero et al., 2002). Yip1p and the
Yip1-related proteins interact with multiple Rabs and in a
manner that depends on carboxy-terminal prenylation of the
Rab protein. Based on these observations, the Yip1 family of
proteins has been proposed to act in the pathway by which
Rab proteins are recruited to membrane compartments
(Calero et al., 2002). Analyses on the mammalian homo-
logue of yeast Yip1p have been undertaken as well. The
mammalian protein Yip1A shares 31% identity with yeast
Yip1p and functionally complements the loss of yeast YIP1
(Calero et al., 2003), indicating a functional conservation of
mechanism. Interestingly, Yip1A localizes to vesicular struc-
tures composing ER export sites, and interacts with the
Sec23/24 subunit of the mammalian COPII complex (Tang
et al., 2001). The authors of this report suggest that Yip1A is
involved in the regulation of ER/Golgi traffic at the level of
ER exit sites. This conclusion is consistent with our findings
that inhibitors of yeast Yip1p function block COPII-depen-
dent budding from the ER and provides support for the hy-
pothesis that Yip1p acts in COPII vesicle biogenesis.
If Yip1p functions in the process of vesicle budding, how
are Yip1p interactions with Rab GTPases integrated into this
model? Rab proteins have been traditionally thought to act
after vesicle formation to regulate the subsequent targeting
and fusion of vesicles to their acceptor membranes (Segev,
2001). However, recent evidence has also suggested a role for
Rab proteins in the process of vesicle formation. For exam-
ple, experiments in mammalian cells indicate that Rab1 acts
during budding to program COPII vesicles for docking and
fusion competency. Here, Rab1 activity was proposed to re-
cruit the vesicle tethering factor p115 into COPII vesicles
to promote targeting to the Golgi apparatus (Allan et al.,
2000). Other reports implicate Rab9 in coordinating cargo
selection with vesicle formation. Specifically, the authors of
this paper suggest that activated Rab9 binds directly to the
protein TIP47, which in turn facilitates the recruitment of
the mannose-6-phosphate receptor into a forming vesicle
(Carroll et al., 2001). Taking these observations into account
when considering Yip1p function, a model can be envi-
sioned in which Yip1p acts to recruit Rabs/Ypts into forming
transport vesicles. In this way, vesicle biogenesis would be
coupled to the incorporation of cargos necessary for the
subsequent docking and fusion of the vesicle. If the ability
of Yip1p to recruit Rabs into forming vesicles is inhibited,
this might then cause overall vesicle formation to become
blocked as well. However, it should be noted that other vesi-
cle proteins required for subsequent fusion, such as the
SNARE proteins Sec22p, Bos1p, Bet1p, rbet1, and mem-
brin, can be efficiently depleted from forming COPII vesi-
cles, yet vesicle formation is not compromised (Allan et al.,
2000; Liu and Barlowe, 2002; Miller et al., 2002).
Although some of the data support a role for Rab proteins
in vesicle formation, additional reports suggest that certain
Rabs are not required for budding, but are required for the
docking and fusion of transport vesicles. For example, sec4
and ypt1 thermosensitive mutant strains accumulate trans-
port vesicles at nonpermissive temperatures (Novick et al.,
1980; Becker et al., 1991). These observations indicate that
Sec4p and Ypt1p are not required for the formation of vesi-
cles that accumulate, but instead act to fuse vesicles to the
correct target membrane. In vitro experiments also demon-
strate that inhibition of Ypt1p activity does not block forma-
tion of COPII vesicles, but inhibits post-budding stages of
transport to the Golgi (Rexach and Schekman, 1991; Segev,
1991; Cao and Barlowe, 2000). Together, these results ar-
gue against a requirement for Ypt1p in COPII vesicle forma-
tion and suggest Yip1p does not rely on Ypt1p in this stage
of transport.
During the course of our investigation, a similar analysis
of Yip1p and Yif1p function in ER/Golgi transport was re-
ported (Barrowman et al., 2003). This report showed that
antibodies directed against Yip1p or Yif1p blocked transport
to the Golgi complex, but only reduced budding efficiencies
by one half. Interestingly, the vesicles formed in the presence
of their inhibitory antibodies failed to fuse with Golgi mem-
branes. In agreement with our findings, their anti-Yip1p an-
tibodies did not inhibit vesicle tethering or fusion when
added after vesicle production. The authors concluded that
the Yip1p–Yif1p complex is required during vesicle forma-
tion to produce fusion competent vesicles (Barrowman et
al., 2003). Although we cannot easily explain the differential
effects of anti-Yip1p antibodies on the level of vesicle bud-
ding, both reports indicate a role for Yip1p function during
COPII vesicle biogenesis. Additional experiments will be
needed to clarify the role of Yip1p in post-budding transport
stages.
Barrowman and colleagues also reported that depletion of
cellular Yip1p did not affect membrane binding or localiza-
tion of Ypt1p (Barrowman et al., 2003). Similarly, we have
observed that thermosensitive mutations in Yip1p and Yif1p
as well as antibodies directed against Yip1p did not inhibit
Ypt1p membrane association in vitro (unpublished data).
Although it is possible that other Yip family members may
drive membrane association of Ypt1p in the absence of
Yip1p and Yif1p, it may be useful to consider a model for
Yip1p function in budding that is independent of Ypt1p or
Rab protein activity. It is also possible that Yip1p serves as a
regulatory checkpoint in vesicle budding to ensure that ER-
derived vesicles can ultimately interact with Rab GTPases.
In such a model, the Rab protein, per se, may not be re-
quired for vesicle budding, but a Rab-binding activity would
be required.
The production of COPII-coated vesicles has been exten-
sively studied in reconstituted budding reactions that use
purified COPII proteins and ER microsomes or defined
synthetic liposomes as the source of donor membrane
(Matsuoka et al., 1998). In contrast to microsomes, budding
from synthetic liposomes requires addition of nonhydrolyz-
able analogs of GTP to prolong the Sar1p-GTP state until
COPII coats assemble. In addition, synthetic liposomes with
an acidic phospholipid content that approximates the com-
position of ER membranes must be used in the minimal
budding reaction. Given these distinct requirements, Yip1p
could serve a role in stabilizing Sar1p-GTP during vesicle
formation from microsomal membranes, or it could influ-
ence local lipid concentrations at transitional ER sites. Fur-
ther investigations are required to fully define the mechanism
of Yip1p in COPII-dependent budding from the ER. One
approach may be to accumulate arrested budding intermedi-T
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ates in the presence of anti-Yip1p antibodies. Such interme-
diates could then be characterized biochemically and mor-
phologically to provide further insights into Yip1p function.
Materials and methods
Yeast strains and media
Yeast strains used in this report are listed in Table II. Unless noted other-
wise, cultures were grown at 25 C (for mutant strains) or 30 C (for wild-
type strains) in rich yeast extract, peptone, dextrose medium (1% Bacto-
yeast extract, 2% Bacto-peptone, and 2% dextrose). Standard yeast (Sherman,
1991) and cloning protocols (Ausubel et al., 1987) were used.
Antibodies and immunoblotting
Antibodies against  1,6-mannose linkages (Cao et al., 1998), Sec12p,
Sec61p, Erv25p, Erv41p, Erv46p, Och1p (Otte et al., 2001), Yif1p (Matern
et al., 2000), and Sec22p (Liu and Barlowe, 2002) have been described
previously. pAbs were raised against a GST-Yip1p (amino-terminal 1–99
aa) fusion protein expressed from plasmid pGEX-2T-YIP1 in Escherichia
coli. The fusion protein was purified according to the manufacturer’s spec-
ifications (Amersham Biosciences) and was used to immunize rabbits by
standard procedures (Covance). Polyclonal anti-Yip1p antibodies were af-
finity purified on an Affi-Gel 15 column with maltose-binding protein–
Yip1p fusion (MBP-Yip1p) coupled as described by the manufacturer (Bio-
Rad Laboratories). MBP-Yip1p (amino-terminal 1–99 aa) was generated
using the expression vector pMAL-c2x (New England Biolabs, Inc.). The
fusion protein was purified according to the manufacturer’s specifications.
Affinity-purified anti-Yip1p Fab fragments and preimmune IgGs were pre-
pared as described previously (Harlow and Lane, 1988). In membrane
fractionation experiments, ER (P13) and Golgi (P100) fractions were pre-
pared as described previously (Belden and Barlowe, 2001a), except that
pellets were resuspended in 0.15 ml SDS-PAGE sample buffer.
In vitro vesicle budding, tethering, and transport assays
Yeast semi-intact cells from wild-type and mutant strains were prepared as
described previously (Baker et al., 1988). Vesicle budding, tethering, and
fusion assays following [
35S]gp f were published previously (Barlowe,
1997; Cao et al., 1998). For two-stage fusion assays with wild-type and
yip1-4 acceptor membranes, wild-type vesicles containing [
35S]gp f were
first isolated from density gradients (Barlowe, 1997). Vesicles were then
added to acceptor membranes to measure fusion (Cao and Barlowe,
2000). Experiments to assay packaging of proteins into vesicles by Western
blot were performed as described previously (Liu and Barlowe, 2002) us-
ing semi-intact cell membranes. For ordering experiments, wild-type semi-
intact cells containing translocated [
35S]gp f were first incubated with ei-
ther COPII proteins or anti-Yip1p antibodies (40  g/ml) for 5 min at 15 C.
Secondary factors were then added, and cells were incubated at 23 C for
an additional 25 min. Reactions were then processed to measure the level
of freely diffusible vesicles (Cao et al., 1998). For in vitro assays, data
points are the average of duplicate determinations and the error bars repre-
sent the range.
Microscopy
For EM experiments, cells were grown overnight to a final cell density of
0.4–0.7 A600. After shift to the restrictive temperature, cells were washed
once with buffer (0.1 M Pipes, 0.1 M sorbitol, and 50 mM KPi, pH 7.3) and
then fixed with fixative (2% glutaraldehyde, 2% PFA, 0.1 M Pipes, pH 6.8,
0.1 M sorbitol, 1 mM MgCl2, 1 mM CaCl2, and 10  M CuCl2) for 1 h at RT
and then overnight at 4 C. The cell walls were removed by treatment with
Table II. Yeast strains used in this paper
Strain Genotype Source
FY834 MAT  his3 200 ura3-52 leu2 1 lys2 202 trp1 63 Winston et al. (1995)
RCY927 MATa sec21-1 ura3-52 leu2-3,112 This paper
RCY1610 MAT  YIP1 KAN
R ura3-52 leu2-3,112 [URA3 CEN YIP1] This paper
RCY1612 MATa YIP1 KAN
R ura3-52 leu2-3,112 [URA3 CEN YIP1] This paper
RCY1633 MATa YIP1 KAN
R ura3-52 leu2-3,112 his 200 [URA3 CEN YIP1 GDI1] This paper
RCY1634 MAT  YIP1 KAN
R ura3-52 leu2-3,112 his 200 [URA3 CEN YIP1 GDI1] This paper
RCY1764 MATa ura3-52 leu2-3,112 YIP1 KAN
R [pRS315 yip1-4] Calero et al. (2003)
RCY1768 MATa ura3-52 leu2-3,112 YIP1 KAN
R [pRS315 YIP1] Calero et al. (2003)
RCY2057 MATa YIP1 KAN
R ura3-52 leu2-3,112 his 200 lys2-801 [URA3 CEN YIP1] This paper
RCY2141 MAT  sec12-4 YIP1 KAN
R ura3-52 leu2-3,112 [URA3 CEN YIP1] This paper
RCY2143 MAT  sec18-1 YIP1 KAN
R ura3-52 leu2-3,112 [URA3 CEN YIP1] This paper
RCY2146 MAT  sec21-1 YIP1 KAN
R ura3-52 leu2-3,112 his 200 [URA3 CEN YIP1 GDI1] This paper
RCY2153 MATa sec13-1 YIP1 KAN
R ura3-52 leu2-3,112 [URA3 CEN YIP1] This paper
RCY2226 MATa sec17ts YIP1 KAN
R ura3-52 leu2-3,112 lys2 [URA3 CEN YIP1 GDI1] This paper
RCY2232 MATa sec22ts YIP1 KAN
R ura3-52 leu2-3,112 [URA3 CEN YIP1 GDI1] This paper
RCY2234 MATa sec16-2 YIP1 KAN
R ura3-52 leu2-3,112 lys2-801 his [URA3 CEN YIP1 GDI1] This paper
RCY2237 MATa sec23-1 YIP1 KAN
R ura3-52 leu2-3,112 his [URA3 CEN YIP1 GDI1] This paper
RCY2239 MAT  ypt1-3 YIP1 KAN
R ura3-52 leu2-3,112 his 200 [URA3 CEN YIP1 GDI1] This paper
RCY2258 MAT  sec18-1 YIP1 KAN
R ura3-52 leu2-3,112 [LEU2 CEN YIP1] This paper
RCY2259 MAT  sec18-1 YIP1 KAN
R ura3-52 leu2-3,112 [LEU2 CEN yip1-4] This paper
RCY2303 MAT  sec20-1 YIP1 KAN
R ura3-52 leu2-3,112 [URA3 CEN YIP1 GDI1] This paper
RCY2318 MATa bos1-1 YIP1 KAN
R ura3-52 leu2-3,112 his 200 [URA3 CEN YIP1 GDI1] This paper
RCY2321 MAT  bet3-1 YIP1 KAN
R ura3-52 leu2-3,112 his [URA3 CEN YIP1 GDI1] This paper
RCY2325 MATa sec17ts YIP1 KAN
R ura3-52 leu2-3,112 lys2 [LEU2 CEN YIP1] This paper
RCY2326 MATa sec17ts YIP1 KAN
R ura3-52 leu2-3,112 lys2 [LEU2 CEN yip1-4] This paper
RCY2384 MAT  sed5ts YIP1 KAN
R ura3-52 leu2-3,112 his [URA3 CEN YIP1 GDI1] This paper
RCY2386 MATa ret1-1 YIP1 KAN
R ura3-52 leu2-3,112 trp1 [URA3 CEN YIP1 GDI1] This paper
RCY2389 MATa uso1-1 YIP1 KAN
R ura3 leu2 his 200 lys2 [URA3 CEN YIP1 GDI1] This paper
RCY2474 MAT  bet1-1 YIP1 KAN
R ura3 leu2 his 200 [URA3 CEN YIP1 GDI1] This paper
RCY2390 MAT  sec35-1 YIP1 KAN
R ura3 leu2 his 200 lys2 [URA3 CEN YIP1 GDI1] This paper
RCY2400 MATa sec34-2 YIP1 KAN
R ura3 leu2 his 200 lys2 [URA3 CEN YIP1 GDI1] This paper
GDI1, GDP dissociation inhibitor 1. Note that the presence of GDI1 is not relevant to these experiments.T
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0.2 mg/ml zymolyase 100T in KPi buffer, pH 7.3 (1 ml/5 OD unit cells). An
aliquot of the cells was collected in a microfuge tube and the pellet was in-
cubated with 2% OsO4 for 1 h followed by incubation with 1% uranyl ac-
etate (aqueous) at 4 C for 30 min. The pellets were dehydrated with se-
quential ethanol washes and incubated with 50% ethanol/50% SPURR
resin (Electron Microscopy Sciences), then changed to 100% SPURR, and
the sample was transferred to beem capsules (Electron Microscopy Sci-
ences) and baked at 70 C for at least 24 h. Thin sections were cut onto
3-mm-diam 75/300-type mesh copper specimen grids (Veco), contrasted
with lead citrate and uranyl acetate, and examined in an electron micro-
scope (model 201; Philips) at 80 kV.
For fluorescence microscopy, the GFP-KDEL construct was generated in
plasmid pRS316 (Sikorski and Hieter, 1989) using standard molecular biol-
ogy techniques. In brief, the construct comprises 363 bp of the KAR2 pro-
moter with 45 amino acids of the Kar2p presequence fused to a linker
(GGPGG) followed by yeast-enhanced GFP (yEGFP; Cormack et al.,
1997), which in turn is followed by second linker (GGPGG) and the se-
quence HDEL. The ADH1 3  region (572 bp) was added after the stop
codon to provide transcription termination. The GFP amino-terminal fu-
sions of GOS1, SED5, and SFT2 were also constructed in plasmid pRS316.
Each construct contains 238 amino acids of yEGFP fused to the start methi-
onine of the tagged protein preceded by a linker (GGPGG). The fusions are
driven by 452 bp of the YOP1 promoter and contain the endogenous gene
terminator (441 bp, 378 bp, and 553 bp of the noncoding 3  region for
SED5, GOS1, and SFT2, respectively). GFP-YIP1 was constructed by in-
serting yEGFP after the initiator methionine in pRS315-YIP1, leaving the
endogenous promoter intact. This construct (pRC693) was expressed at
wild-type levels in haploid cells as the only source of YIP1. Cells contain-
ing GFP fusion plasmids were examined with a microscope (Eclipse E600;
Nikon) equipped with a 60  objective and 2  optovar. A Spot-RT mono-
chrome CCD camera (Diagnostic Instruments)with version 3.5 software
was used for image capture. All images shown are representative images
from cells during logarithmic phase growth in minimal media supple-
mented as necessary.
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